Related Experiment Video
Updated: Feb 7, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Antifungal medication is efficient in the treatment of sarcoidosis
Marjeta Tercelj1, Barbara Salobir, Mirjana Zupancic
1Clinic of Pulmonary Disease and Allergy, University Medical Centre, Zaloska 7, 1000 Ljubljana, Slovenia. marjeta.tercelj@kclj.si
Objectives:
Fungi have been suspected of contributing to the pathogenesis of sarcoidosis. A previous intervention study demonstrated an improvement in the clinical condition in 15 out of 18 patients with a long-term history of sarcoidosis when antifungal medication was added to corticosteroids. The present study was performed to compare the effects of antifungal treatment with corticosteroid treatment in sarcoidosis.
Methods:
Patients with newly diagnosed sarcoidosis were recruited. Corticosteroids were given to 39 subjects, corticosteroid + antifungal to 31, and antifungal only to 22 subjects. The effects of the treatments were evaluated at 6 months. X-ray scores were measured before and after treatment together with pulmonary diffusion capacity and two markers of sarcoidosis activity, that is, angiotensin-converting enzyme in serum (sACE) and chitotriosidase (CTO).
Results:
X-ray scores as well as sACE and CTO decreased significantly in all groups. The X-ray score decreased slightly more among subjects in the groups that received antifungal medication compared with corticosteroids only (p < 0.001).
Conclusion:
The results suggest that antifungal treatment is as efficient as corticosteroid treatment against the granulomatous and inflammatory manifestations of sarcoidosis. This is probably because this treatment is directed towards the causative agent. Additional studies are required to define the phenotype, where the antifungal treatment was not efficient (4/22) and to perform long-term follow up to determine the risk of recurrence.
Insights
Antifungal treatment shows comparable efficacy to corticosteroids in managing sarcoidosis symptoms. This suggests a potential role for antifungals in treating this granulomatous disease.
Area of Science:
- Pulmonology
- Immunology
- Infectious Diseases
Background:
- Fungal involvement is suspected in sarcoidosis pathogenesis.
- Previous studies indicated benefits of antifungal therapy combined with corticosteroids.
Purpose of the Study:
- To compare the efficacy of antifungal treatment versus corticosteroid treatment in sarcoidosis.
- To evaluate treatment effects on clinical and biomarker indicators of sarcoidosis.
Main Methods:
- Newly diagnosed sarcoidosis patients were assigned to corticosteroid, corticosteroid + antifungal, or antifungal-only groups.
- Treatment outcomes were assessed at 6 months using X-ray scores, pulmonary diffusion capacity, serum angiotensin-converting enzyme (sACE), and chitotriosidase (CTO).
Main Results:
- Significant reductions in X-ray scores, sACE, and CTO were observed across all treatment groups.
- Antifungal-inclusive groups showed a slightly greater reduction in X-ray scores compared to corticosteroids alone (p < 0.001).
Conclusions:
- Antifungal treatment appears as effective as corticosteroids for sarcoidosis's granulomatous and inflammatory aspects.
- Further research is needed to identify patient phenotypes benefiting most from antifungal therapy and assess long-term recurrence risks.
Related Concept Videos
Heart Failure V: Medical Management
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Pericarditis III: Medical Management
Inhaled Medications

